Trial Shows RA Can Be Stopped at Preclinical Stage

(MedPage Today) -- MILAN -- One year of treatment with abatacept (Orencia) kept "preclinical" rheumatoid arthritis (RA) from becoming clinical in most patients showing signs of imminent onset, a researcher reported here. In a phase IIb randomized...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news